Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 4,218 | 5,852 | 6,525 | 13,996 | 9,877 |
| Gross Profit | 4,218 | 5,852 | 6,525 | 13,996 | 9,877 |
| Operating Expenses | 79,480 | 84,755 | 39,724 | 34,817 | 34,190 |
| Operating Income | -75,262 | -78,903 | -33,199 | -20,821 | -24,313 |
| Interest Expense | 2,430 | 115 | 64 | 26 | 36 |
| Other Income | 440 | 212 | 143 | 206 | -21 |
| Pre-tax Income | -77,252 | -78,806 | -33,120 | -20,641 | -24,370 |
| Net Income Continuous | -77,252 | -78,806 | -33,120 | -20,641 | -24,370 |
| Net Income | $-77,252 | $-78,806 | $-33,120 | $-20,641 | $-24,370 |
| EPS Basic Total Ops | -5.80 | -6.00 | -2.40 | -1.60 | -2.00 |
| EPS Basic Continuous Ops | -5.72 | -5.95 | -2.46 | -1.54 | -2.02 |
| EPS Diluted Total Ops | -5.80 | -6.00 | -2.40 | -1.60 | -2.00 |
| EPS Diluted Continuous Ops | -5.72 | -5.95 | -2.46 | -1.54 | -2.02 |
| EBITDA(a) | $-72,925 | $-78,222 | $-31,285 | $-19,169 | $-22,577 |